Skip to main content

1 Result(s)

within Bohrane Slama Remove this filter

and

  1. No Access

    Article

    Treatment of myelodysplastic syndromes with excess of blasts by bevacizumab is well tolerated and is associated with a decrease of VEGF plasma level

    Myelodysplastic syndromes (MDS) are associated with increased bone marrow vascularity and increased levels of various angiogenic factors including Vascular Endothelial Growth Factor (VEGF) which is implicated ...

    Laurence Legros, Bohrane Slama, Jean-Michel Karsenti, Norbert Vey… in Annals of Hematology (2012)